| dc.contributor.author | Soleimanpour, H | |
| dc.contributor.author | Aghamohammadi, D | |
| dc.contributor.author | Ghaffarzad, A | |
| dc.contributor.author | Golzari, SE | |
| dc.contributor.author | Safari, S | |
| dc.contributor.author | Soleimanpour, M | |
| dc.date.accessioned | 2018-08-26T06:04:26Z | |
| dc.date.available | 2018-08-26T06:04:26Z | |
| dc.date.issued | 2014 | |
| dc.identifier.uri | http://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/41446 | |
| dc.description.abstract | A patient with refractory trigeminal neuralgia (tic douloureux) was treated by intravenous magnesium sulfate successfully. Parenteral magnesium sulfate is an analgesic that expresses its analgesic effects through a noncompetitive blockade of the N-methyl-D-aspartate (NMDA) receptors, which in turns inhibits calcium entry into the cells. | |
| dc.language.iso | English | |
| dc.relation.ispartof | Journal of clinical anesthesia | |
| dc.subject | Aged | |
| dc.subject | Analgesics, Non-Narcotic | |
| dc.subject | Humans | |
| dc.subject | Injections, Intravenous | |
| dc.subject | Magnesium Sulfate | |
| dc.subject | Male | |
| dc.subject | Pain, Intractable | |
| dc.subject | Receptors, N-Methyl-D-Aspartate | |
| dc.subject | Trigeminal Neuralgia | |
| dc.title | Novel treatment in refractory tic douloureux. | |
| dc.type | article | |
| dc.citation.volume | 26 | |
| dc.citation.issue | 6 | |
| dc.citation.spage | 495 | |
| dc.citation.epage | 6 | |
| dc.citation.index | Pubmed | |
| dc.identifier.DOI | https://doi.org/10.1016/j.jclinane.2014.03.011 | |
